Neridronate in the treatment of thalassemia-induced osteoporosis

被引：0
|
作者：
不详
机构：
来源：
CALCIFIED TISSUE INTERNATIONAL | 2006年 / 78卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S138 / S138
页数：1
相关论文
共 50 条
  • [31] Serum Dickkopf-1 Is Increased and Correlates with Bone Mineral Density in Patients with Thalassemia-induced Osteoporosis. Reduction Post Zoledronic Acid Administration
    Voskaridou, Ersi
    Christoulas, Dimitrios
    Pantelaros, Thodoris
    Varvagiannis, Konstantinos
    Xirakia, Charoula
    Papatheodorou, Athanasios
    Sinopoulou, Kleio
    Mpalasopoulou, Aggeliki
    Bilalis, Antonios
    Terpos, Evangelos
    BLOOD, 2008, 112 (11) : 1325 - 1326
  • [32] Treatment options for thalassemia patients with osteoporosis
    Terpos, Evangelos
    Voskaridou, Ersi
    COOLEY'S ANEMIA: NINTH SYMPOSIUM, 2010, 1202 : 237 - 243
  • [33] Successful neridronate therapy in transient osteoporosis of the hip
    La Montagna, G
    Malesci, D
    Tirri, R
    Valentini, G
    CLINICAL RHEUMATOLOGY, 2005, 24 (01) : 67 - 69
  • [34] SERUM DICKKOPF-1 IS INCREASED AND CORRELATES WITH BONE MINERAL DENSITY IN PATIENTS WITH THALASSEMIA-INDUCED OSTEOPOROSIS. REDUCTION POST ZOLEDRONIC ACID ADMINISTRATION
    Voskaridou, E.
    Christoulas, D.
    Xirakia, C.
    Varvagiannis, K.
    Boutsikas, G.
    Terpos, E.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 : 357 - 357
  • [35] Superior repositioning of the maxilla in thalassemia-induced facial deformity: Report of 3 cases and a review of the literature
    Mortazavi, Seyyed Hossein
    Khojasteh, Arash
    JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY, 2007, 65 (05) : 1023 - 1031
  • [36] Intravenous neridronate is effective in regional migratory osteoporosis
    D'Alessandro, Roberto
    Falsetti, Paolo
    Bardelli, Marco
    Gentileschi, Stefano
    Baldi, Caterina
    Conticini, Edoardo
    Cantarini, Luca
    Frediani, Bruno
    RHEUMATOLOGY, 2022, 61 (10) : E311 - E313
  • [37] Efficacy of intravenous neridronate in transient osteoporosis of the hip
    D'Alessandro, R.
    Falsetti, P.
    Conticini, E.
    Bardelli, M.
    Baldi, C.
    Gentileschi, S.
    Nicosia, A.
    Al Khayyat, S. G.
    Cantarini, L.
    Frediani, B.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2022, 40 (09) : 1681 - 1685
  • [38] Acute Pseudogout Following Intravenous Neridronate for Osteoporosis
    Carda, Stefano
    Invernizzi, Marco
    Sainaghi, Pier Paolo
    Cisari, Carlo
    JOURNAL OF RHEUMATOLOGY, 2010, 37 (05) : 1076 - 1077
  • [39] Successful neridronate therapy in transient osteoporosis of the hip
    Giovanni La Montagna
    Domenico Malesci
    Rosella Tirri
    Gabriele Valentini
    Clinical Rheumatology, 2005, 24 : 67 - 69
  • [40] Clinical and biochemical response to neridronate treatment in a patient with osteoporosis-pseudoglioma syndrome (OPPG)
    Celli, M.
    D'Eufemia, P.
    Persiani, P.
    Turchetti, A.
    Febbo, A.
    D'Alfonso, Y.
    Celli, L.
    Zambrano, A.
    OSTEOPOROSIS INTERNATIONAL, 2017, 28 (11) : 3277 - 3280
12345